CytoSorbents' $43,000 Lean Quarter
A micro-cap finally stops burning cash — by cutting the sales force that was supposed to grow it, while the De Novo filing slips to 'early 2027' yet again
CTSO · Earnings Call · 2026-11-12
Breakeven, With an Asterisk
On November 12, CytoSorbents (market cap ~$17M) reported its third quarter of 2026 and delivered something it has not delivered in years: a positive number where the cash-burn figure usually sits. As CEO Phillip Chan put it, “We generated approximately $43,000 of positive operating cash flow on that basis.” — Phillip Chan, Chief Executive Officer · 2026-11-12 That "basis" is doing a lot of work — it excludes restructuring-related payments — but the milestone is real enough that management led with it. The mechanics are genuinely cleaner than the headline. Product gross margin hit 75%, and CFO Peter Mariani walked the bridge explicitly: “Product gross margin was 75%, up approximately 2 points from 73% in the second quarter and 5 points from 70% a year ago.” — Peter Mariani, Chief Financial Officer · 2026-11-12 Operating expenses fell 11% year-over-year, the adjusted EBITDA loss narrowed to roughly $300,000, and inventory was drawn down. These are the fingerprints of cost controls and better manufacturing yield rather than demand. That is the tell. The breakeven was engineered from the cost line, not earned from the top line. Gross margin stood at 73.2% in the most recent filing and has now pushed into the mid-70s on the call, but total revenue has been stuck near $10M a quarter since 2021. You can only cut your way to breakeven once.The Cost-Cut That Cut Growth
Here is where the report earns its tension. The quarter's worst number belongs to Germany — the company's largest direct market, roughly a quarter of sales — and management was unusually candid about why it is shrinking:This is not new information so much as a confession that has been dawning for several quarters. Back in March, Chan framed Germany as a slow repair: “we expect to see incremental improvement over time. Now it's not going to happen suddenly as there's still a lot of work to do.” — Phillip Chan, Chief Executive Officer · 2026-03-25 By May he was promising to get the country “beyond treading water and staying even to actually returning to growth.” — Phillip Chan, Chief Executive Officer · 2026-05-13 Now, three calls on, the market is down 20% and the fix is to re-hire the reps they cut — two already added, more planned into early 2027. The company optimized its P&L by starving the very channel that generates profitable growth. The offsetting channels are the real bright spot: distributor and strategic partner sales rose 18% year-over-year, and direct international sales outside Germany grew 4%, together 76% of the quarter. A leaner company is riding international distributors while it rebuilds its own feet on the street.Germany, representing the remaining 24%, declined approximately 20%-21% year-over-year, principally because we reduced our sales force and territory coverage during restructuring, not because we believe the market opportunity has disappeared.